Company: WELNF
Filing Date: 2025-08-06
Form Type: 425
Source: 0001104659-25-074443
Chunk: 3

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-08-06
Form: 425
Chunk 3
---
 the risk that the proposed Business Combination may not be completed in a timely manner or at all, which
may adversely affect the price of WEL’s securities; (ii) the risk that the proposed Business Combination may not be completed by
WEL’s business combination deadline and the potential failure to obtain an extension of the business combination deadline if sought
by WEL; (iii) the failure to satisfy the conditions to the consummation of the Business Combination, including the approval of the Business
Combination Agreement by the shareholders of WEL; (iv) the occurrence of any event, change or other circumstance that could give rise
to the termination of the Business Combination Agreement; (v) the failure to achieve the minimum amount of cash available following any
redemptions by WEL’s shareholders; (vi) redemptions exceeding a maximum threshold or the failure to meet the Nasdaq’s initial
listing standards in connection with the consummation of the contemplated Business Combination; (vii) the effect of the announcement or
pendency of the Business Combination on Btab’s business relationships, operating results, and business generally; (viii) risks that
the proposed Business Combination disrupts current plans and operations of Btab; (ix) the outcome of any legal proceedings that may be
instituted against Btab or against WEL related to the Business Combination Agreement or the proposed Business Combination; (x) changes
in the markets in which Btab competes, including with respect to its competitive landscape, technology evolution or regulatory changes;
(xi) changes in domestic and global general economic conditions; (xii) risk that Btab may not be able to execute its growth strategies;
(xiii) risk that Btab may not be able to develop and maintain effective internal controls; (xiv) costs related to the Business Combination
and the failure to realize anticipated benefits of the Business Combination or to realize estimated pro forma results and underlying assumptions,
including with respect to estimated shareholder redemptions; (xv) the ability to recognize the anticipated benefits of the proposed Business
Combination and to achieve its commercialization and development plans, and identify and realize additional opportunities, which may be
affected by, among other things, competition, the ability of Btab to grow and manage growth economically and hire and retain key employees;
(xvi) Btab’s limited operating history, its limited financial resources, domestic or global economic conditions, activities of competitors,
and the presence of new or additional competition, and conditions of equity markets; and (